US Market Growth STRATEC expanded its US presence through the 2023 Natech Plastics acquisition, signaling a ready channel to target US diagnostics labs and OEMs. This footprint creates opportunities to sell integrated automation systems, smart consumables, and platform modules to US customers seeking domestically supported, end-to-end solutions.

Turnkey Automation STRATEC’s capabilities across development, design, production and quality assurance position it as a one-stop partner for clinical diagnostics OEMs and labs seeking turnkey automation solutions, reducing vendor fragmentation and enabling faster time-to-market.

Modular Platform Upsell The introduction of stand-alone modules and a chemiluminescence immunoassay platform demonstrates a modular, scalable product strategy that can be upsold to existing customers and extended to new markets as demand for flexible automation grows.

Digital Analytics With a technology stack that includes SAP, .NET and cloud-related components, STRATEC can offer integrated software, data analytics and remote monitoring to improve laboratory throughput, traceability and predictive maintenance for partner labs.

Cost Reduction Given recent revenue pressures and one-time impairment impacts, STRATEC can position its automation and smart consumables as a lever to reduce manual labor and operating costs for high-volume diagnostics labs and life sciences customers.